449 related articles for article (PubMed ID: 19164225)
1. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
[TBL] [Abstract][Full Text] [Related]
2. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma.
Tharp K; Israel O; Hausmann J; Bettman L; Martin WH; Daitzchman M; Sandler MP; Delbeke D
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1435-42. PubMed ID: 15221294
[TBL] [Abstract][Full Text] [Related]
3. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
[TBL] [Abstract][Full Text] [Related]
4. Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a
Spanu A; Nuvoli S; Marongiu A; Gelo I; Mele L; Piras B; Madeddu G
BMC Cancer; 2020 Mar; 20(1):239. PubMed ID: 32197595
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma.
Yamamoto Y; Nishiyama Y; Monden T; Matsumura Y; Satoh K; Ohkawa M
J Nucl Med; 2003 Dec; 44(12):1905-10. PubMed ID: 14660715
[TBL] [Abstract][Full Text] [Related]
6. Scintigraphic TNM staging of tumors: a proposition.
Oommen R
J Nucl Med; 2009 Aug; 50(8):1386; author reply 1386. PubMed ID: 19617337
[No Abstract] [Full Text] [Related]
7. Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT.
Barwick T; Murray I; Megadmi H; Drake WM; Plowman PN; Akker SA; Chew SL; Grossman AB; Avril N
Eur J Endocrinol; 2010 Jun; 162(6):1131-9. PubMed ID: 20212015
[TBL] [Abstract][Full Text] [Related]
8. Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.
Wong KK; Sisson JC; Koral KF; Frey KA; Avram AM
AJR Am J Roentgenol; 2010 Sep; 195(3):730-6. PubMed ID: 20729453
[TBL] [Abstract][Full Text] [Related]
9. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
10. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.
Grewal RK; Tuttle RM; Fox J; Borkar S; Chou JF; Gonen M; Strauss HW; Larson SM; Schöder H
J Nucl Med; 2010 Sep; 51(9):1361-7. PubMed ID: 20720058
[TBL] [Abstract][Full Text] [Related]
11. 131I SPECT/CT in the follow-up of patients with differentiated thyroid carcinoma.
Menges M; Uder M; Kuwert T; Schmidt D
Clin Nucl Med; 2012 Jun; 37(6):555-60. PubMed ID: 22614186
[TBL] [Abstract][Full Text] [Related]
12. Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma.
Wong KK; Zarzhevsky N; Cahill JM; Frey KA; Avram AM
AJR Am J Roentgenol; 2008 Dec; 191(6):1785-94. PubMed ID: 19020251
[TBL] [Abstract][Full Text] [Related]
13. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
Rubello D; Mazzarotto R; Casara D
Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
[TBL] [Abstract][Full Text] [Related]
14. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation.
Schmidt D; Szikszai A; Linke R; Bautz W; Kuwert T
J Nucl Med; 2009 Jan; 50(1):18-23. PubMed ID: 19091884
[TBL] [Abstract][Full Text] [Related]
15. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
[TBL] [Abstract][Full Text] [Related]
16. The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer.
Wang H; Fu HL; Li JN; Zou RJ; Gu ZH; Wu JC
Clin Imaging; 2009; 33(1):49-54. PubMed ID: 19135930
[TBL] [Abstract][Full Text] [Related]
17. Role of Diagnostic
Spanu A; Nuvoli S; Gelo I; Mele L; Piras B; Madeddu G
J Nucl Med; 2018 Oct; 59(10):1510-1515. PubMed ID: 29496990
[TBL] [Abstract][Full Text] [Related]
18. Five months' follow-up of patients with and without iodine-positive lymph node metastases of thyroid carcinoma as disclosed by (131)I-SPECT/CT at the first radioablation.
Schmidt D; Linke R; Uder M; Kuwert T
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):699-705. PubMed ID: 19936746
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of single-photon emission computed tomography/computed tomography in post-ablation
Jiang L; Xiang Y; Huang R; Tian R; Liu B
Pediatr Radiol; 2021 Aug; 51(9):1724-1731. PubMed ID: 33759024
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 123I scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer.
Shankar LK; Yamamoto AJ; Alavi A; Mandel SJ
J Nucl Med; 2002 Jan; 43(1):72-6. PubMed ID: 11801706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]